Pharma Equity Group A/S Quality Score
PEG.XCSE
Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.
Broad-market heuristics · Not a buy/sell signal
Valuation and growth
Growth
FCF negative, burning cash after capex
Business Quality & Capital Allocation
Heavy dilution above 5%
Positive debt with no FCF to service it
Below 8%, may not cover cost of capital
Peers
Biotechnology · Pick stocks to compare with PEG.XCSE
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PEG.XCSE
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.